Mimetics, LLC
Software pipeline for analyzing biological network dynamics from time-series data, including preprocessing, node/edge detection algorithms, statistical integration, and visualization
- Sector
- Biotech
- Total capital
- $225K
- Federal grants
- $225K
- 1 award · 2016
- Rank in peer group#19 of 28
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2021
- Rank in peer group#5 of 28
Capital timeline
Latest events
- Federal grantNSF · Phase I · SBIR Phase I: Computational Tools for Analyzing the Dynamics of Biological Processes$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 28 peers
Line = medianBiotech · Software
- Federal grantsBelow median
- Granted patents#5 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 4- PendingMethods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromUSPTOApplication 19324968
- PendingMethods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromUSPTOApplication 17360695
- GrantedMethods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromUSPTOUS 11,078,515
Show all 4 patent records
- Methods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromMar 12, 2026 · Application 19324968Pending
- Methods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromNov 11, 2021 · Application 17360695Pending
- Methods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromAug 3, 2021 · US 11,078,515Granted
- Methods For Identifying Targets For Antimicrobial And Antiproliferative Compounds And Compositions TherefromApplication PCTUS2016031712Pending
Related companies, and why
- SELSYM BIOTECH INCSimilar federal contract value in Biotech · null in contracts
- GROVE BIOPHARMA, INC.Similar federal contract value in Biotech · null in contracts
- NEUROLUCENT, INC.Similar federal contract value in Biotech · null in contracts
- Granite BioSimilar federal contract value in Biotech · null in contracts
- Emalex BiosciencesSimilar federal contract value in Biotech · null in contracts
- ChemomabSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .